XHSvsGNOMETF Comparison
State Street SPDR S&P Health Care Services ETF (XHS) belongs to the US Health Care segment. Global X Genomics & Biotechnology ETF (GNOM) is part of the BioTech & Genomics segment. XHS's top 3 sector exposures are Healthcare, Consumer Non-Cyclicals and Business Services. XHS is less expensive with a Total Expense Ratio (TER) of 0.35%, versus 0.5% for GNOM. XHS is up 26.65% year-to-date (YTD) with +$111M in YTD flows. GNOM performs better with 39.43% YTD performance, and +$17M in YTD flows. Run a side-by-side ETF comparison of XHS and GNOM below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
XHS vs GNOM performance and flow charts
Performance
Cumulative Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | XHS GNOM | -1.08%+6.48% | +16.30%+32.91% | +26.65%+39.43% | +35.80%+72.43% | +58.89%+47.52% | +23.34%-32.80% |
| Flows | XHS GNOM | +$12M-$688K | +$99M+$15M | +$111M+$17M | +$112M+$12M | +$72M-$57M | +$10M-$41M |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | XHS GNOM | +18.63%+38.16% | +17.60%+30.61% | +18.29%+30.38% | +21.34%+33.83% |
| Max drawdown | XHS GNOM | -4.21%-8.57% | -11.97%-18.16% | -14.46%-43.10% | -29.93%-71.04% |
| Max drawdown duration | XHS GNOM | 65d32d | 121d145d | 250d674d | 1477d1815d |
XHS | GNOM | |
Last sale 9/9/2026 at 3:10 PM | $134.82 | $62.86 |
| Previous close 09/08/2026 | $135.28 | $63.44 |
| Consolidated volume 09/08/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
XHS | GNOM | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
XHS | GNOM | |
|---|---|---|
| Last price | $134.82 | $62.86 |
| 1D performance | -0.34% | -0.92% |
| AuM | $220.51 M | $92.27 M |
| E/R | 0.35% | 0.5% |
XHS | GNOM | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | State Street Investment Management | Global X |
| Benchmark | S&P Health Care Services Select Industry Index | Solactive Genomics Index |
| N° of holdings | 60 | - |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | September 28, 2011 | April 5, 2019 |
| ESG | No | No |
Countries
Sectors
Diversification
Total weight of top 15 holdings out of 15
